The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device ...

GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal ...

Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...

Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston ...

The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the ...

The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer ...

More generous subsidies for Affordable Care Act plans have helped millions of Americans afford insurance. Chances are ...

By targeting ambulatory surgery centers, the company is gearing up to compete with Intuitive Surgical for an emerging ...